IL-17A在大鼠房顫模型中的作用和機(jī)制研究
發(fā)布時(shí)間：2018-09-17 18:19
【摘要】：背景房顫是臨床上最常見的心律失常之一。近年來,一類新的輔助性T細(xì)胞亞群-Th17細(xì)胞(T help cell 17,Th17)及其特異性效應(yīng)因子白介素-17(interleukin-17,IL17)備受關(guān)注,IL-17被證明是一種重要的炎癥反應(yīng)介質(zhì)。研究發(fā)現(xiàn),IL-17在多種心血管疾病的發(fā)生發(fā)展中發(fā)揮了重要的作用,包括動(dòng)脈粥樣硬化、慢性心力衰竭、急性冠狀動(dòng)脈綜合征和病毒性心肌炎。但是目前關(guān)于IL-17與房顫發(fā)生相關(guān)的研究證據(jù)尚較少。為探索IL-17是否是房顫的獨(dú)立危險(xiǎn)因素和重要的炎癥標(biāo)記物,本課題組前期通過配對(duì)的病例對(duì)照研究發(fā)現(xiàn),外周血漿中IL-17A與房顫發(fā)生相關(guān)聯(lián),且隨著因子水平增高,關(guān)聯(lián)強(qiáng)度越強(qiáng),且可能通過影響心臟結(jié)構(gòu)重構(gòu)而影響房顫發(fā)生。但是IL-17A在房顫發(fā)生和維持中的具體作用和機(jī)制如何,外周血和心房組織中IL-17A水平是否存在一致性,仍有待進(jìn)一步研究。目的本課題利用SD大鼠,通過食道快速心房起搏的方法來構(gòu)建房顫動(dòng)物模型,進(jìn)一步探討IL-17與房顫發(fā)生的關(guān)聯(lián),分析外周血中IL-17A水平與心房組織中是否存在一致性及二者與心房纖維化的相關(guān)性。同時(shí),分析IL-17A與基質(zhì)金屬蛋白酶(matrix metalloproteinase,MMP)、基質(zhì)金屬蛋白酶抑制劑(tissue inhibitor metalloproteinase,TIMP)之間的相關(guān)性,進(jìn)一步驗(yàn)證IL-17A通過引起MMPs/TIMPs失衡誘導(dǎo)心房纖維化的機(jī)制。研究結(jié)果將為IL-17作為房顫早期診斷和監(jiān)測(cè)疾病進(jìn)展的重要生物標(biāo)記物提供依據(jù),也將為全面認(rèn)識(shí)房顫發(fā)生和維持的機(jī)制以及尋找新的治療靶點(diǎn)提供參考依據(jù)。方法1.采用經(jīng)食道快速心房起搏的方法構(gòu)建大鼠房顫模型,比較分析房顫組與對(duì)照組心電數(shù)據(jù)的變化,包括QRS間期、QT間期等,以及兩組心房纖維化程度的改變。2.通過酶聯(lián)免疫吸附法測(cè)定房顫組與對(duì)照組血漿中IL-17A與C反應(yīng)蛋白(c-reactive protein,CRP)水平的變化,以及兩組血漿中MMP2、MMP9、TIMP2的水平。3.采用免疫組化法測(cè)定兩組心房組織中IL-17A、MMP2、MMP9及TIMP2的水平。4.采用Pearson相關(guān)分析的方法,分析血漿和心房組織中IL-17A的一致性及二者與心房纖維化的相關(guān)性,同時(shí)分析血漿和心房組織中MMP2、MMP9、TIMP2的一致性及三者與心房纖維化的相關(guān)性,血漿和心房組織中MMP2、MMP9、TIMP2與IL-17A的相關(guān)性。結(jié)果第一章大鼠房顫模型的構(gòu)建1.房顫組大鼠的心率顯著加快,正常時(shí)為(159.63±18.25)次/min,房顫發(fā)作時(shí)達(dá)(203.24±33.56)次/min,同時(shí),QRS間期和QT間期明顯延長(zhǎng),分別由正常時(shí)的50.00±4.28 ms,103.00±1.85 ms增加至68.85±14.73 ms和134.80±22.05 ms,差異均有統(tǒng)計(jì)學(xué)意義(P0.05)。2.房顫組大鼠心房纖維化程度較對(duì)照組嚴(yán)重,膠原容積分?jǐn)?shù)較對(duì)照組明顯升高[(18.15±9.45)%vs(6.51±4.49)%,P0.01]。第二章大鼠房顫模型中IL-17A的作用及其與心房纖維化的關(guān)聯(lián)研究1.大鼠外周血血漿中IL-17A和CRP的水平與房顫的發(fā)生密切相關(guān),且隨房顫發(fā)生次數(shù)的增多有上升趨勢(shì)。2.房顫組大鼠心房組織中IL-17A的蛋白表達(dá)水平較對(duì)照組明顯升高(0.17±0.05vs 0.04±0.01,P=0.003)。3.房顫組大鼠外周血血漿中IL-17A水平與心房組織中IL-17A水平存在高度相關(guān)性(r=0.721,P=0.019)。血漿中IL-17A水平與心房纖維化呈正相關(guān)(r=0.830,P=0.003),心房組織中IL-17A水平與心房纖維化也呈正相關(guān)(r=0.685,P=0.029)。第三章大鼠房顫模型中IL-17A與MMPs/TIMPs的關(guān)聯(lián)研究1.尚未發(fā)現(xiàn)房顫組與對(duì)照組大鼠外周血血漿中MMP2、MMP9、TIMP2水平存在統(tǒng)計(jì)學(xué)差異。2.與對(duì)照組相比,房顫組大鼠心房組織中MMP2、MMP9水平明顯升高(0.12±0.05vs 0.04±0.02,P=0.021;0.08±0.01 vs 0.03±0.01,P0.001),而TIMP2水平在房顫組明顯降低(0.02±0.00 vs 0.06±0.02,P=0.004)。3.房顫組大鼠外周血血漿和心房組織中MMP2、MMP9、TIMP2的水平存在高度相關(guān)性,心房組織中MMP9水平與心房纖維化呈正相關(guān)(r=0.809,P=0.005),TIMP2水平與心房纖維化呈負(fù)相關(guān)(r=-0.884,P=0.001),未發(fā)現(xiàn)心房組織中MMP2水平與心房纖維化之間的相關(guān)性(r=0.599,P=0.067)。4.房顫組大鼠外周血血漿中MMP9水平與IL-17A呈正相關(guān)(r=0.648,P=0.043),TIMP2水平與IL-17A呈負(fù)相關(guān)(r=-0.695,P=0.037),未發(fā)現(xiàn)血漿中MMP2與IL-17A水平之間的相關(guān)性(r=0.576,P=0.082)。5.房顫組大鼠心房組織中MMP2、MMP9與IL-17A水平均呈正相關(guān)(r=0.801,P=0.005;r=0.778,P=0.008),TIMP2與IL-17A水平呈負(fù)相關(guān)(r=-0.841,P=0.002)。結(jié)論通過大鼠房顫動(dòng)物模型研究,發(fā)現(xiàn)IL-17A與房顫的發(fā)生發(fā)展密切相關(guān),IL-17A可能是通過影響MMPs/TIMPs平衡,引起心房結(jié)構(gòu)重構(gòu),從而導(dǎo)致房顫的發(fā)生與發(fā)展。
[Abstract]:Background Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. In recent years, a new helper T cell subset-Th17 (Th17) and its specific effector interleukin-17 (IL-17) have attracted much attention. IL-17 has been proved to be an important inflammatory mediator in many cardiovascular diseases. Interleukin-17 (IL-17) plays an important role in the development of atrial fibrillation, including atherosclerosis, chronic heart failure, acute coronary syndrome and viral myocarditis. Phase I matched case-control study showed that IL-17A in peripheral plasma was associated with AF, and with the increase of factor levels, the stronger the association was, and it may affect AF by affecting cardiac structural remodeling. However, the specific role and mechanism of IL-17A in the occurrence and maintenance of AF, and the role of IL-17A in peripheral blood and atrial tissue were also discussed. Objective To explore the relationship between IL-17 and atrial fibrillation in SD rats by rapid esophageal atrial pacing, and to analyze the consistency of IL-17A level in peripheral blood with atrial tissue and the relationship between them and atrial fibrosis. The correlation between IL-17A and matrix metalloproteinase (MMP) and tissue inhibitor metalloproteinase (TIMP) was analyzed to further validate the mechanism of IL-17A inducing atrial fibrosis by inducing imbalance of MMPs/TIMPs. Methods 1. A rat model of atrial fibrillation was established by transesophageal rapid atrial pacing, and the changes of electrocardiogram data, including QRS, were compared and analyzed between atrial fibrillation group and control group. The changes of plasma levels of IL-17A and C-reactive protein (CRP) and plasma levels of MMP2, MMP9 and TIMP 2 in AF group and control group were measured by enzyme-linked immunosorbent assay. 3. The levels of IL-17A, MMP2 and MMP in atrial tissues were determined by immunohistochemistry. Pearson correlation analysis was used to analyze the consistency of IL-17A in plasma and atrial tissues and their correlation with atrial fibrosis. The consistency of MMP2, MMP9, TIMP2 in plasma and atrial tissues and their correlation with atrial fibrosis were also analyzed. Result The first chapter was the establishment of rat atrial fibrillation model. 1. The heart rate of rats in AF group increased significantly from (159.63 (+ 18.25) beats per minute in normal time to (203.24 (+ 33.56) beats per minute in AF attack. Meanwhile, the QRS interval and QT interval prolonged significantly from 50.00 (+ 4.28 ms), 103.00 (+ 1.85 ms) to 68.85 (+ 14.73 ms) and 134.80 (+ 22.05) beats in normal time, respectively. The degree of atrial fibrosis in AF group was more serious than that in control group. The volume fraction of collagen in AF group was significantly higher than that in control group [(18.15+9.45)% vs (6.51+4.49)%, P 0.01]. The level of IL-17A in atrial tissue of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). 3. The level of IL-17A in plasma of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). The level of IL-17A in plasma was positively correlated with atrial fibrosis (r = 0.830, P = 0.003), and the level of IL-17A in atrial tissue was positively correlated with atrial fibrosis (r = 0.685, P = 0.029). Compared with the control group, the levels of MMP 2 and MMP 9 in atrial tissue of AF group were significantly higher (0.12.05 vs 0.04.02, P = 0.021; 0.08.01 vs 0.03.01, P 0.001), while the levels of TIMP 2 were significantly lower in AF group (0.02.00 vs 0.06.02, P = 0.004). The levels of MMP 2, MMP 9 and TIMP 2 in atrial tissues were positively correlated with atrial fibrosis (r = 0.809, P = 0.005). The levels of TIMP 2 were negatively correlated with atrial fibrosis (r = - 0.884, P = 0.001). No correlation was found between the levels of MMP 2 in atrial tissues and atrial fibrosis (r = 0.599, P = 0.067). 4. The levels of MMP-9 in plasma were positively correlated with IL-17A (r = 0.648, P = 0.043), and TIMP-2 was negatively correlated with IL-17A (r =-0.695, P = 0.037). No correlation was found between the levels of MMP-2 and IL-17A (r = 0.576, P = 0.082). MMP-2, MMP-9 and IL-17A were positively correlated in atrial tissues of AF rats (r = 0.801, P = 0.005; r = 0.778, P = 0.008). Conclusion IL-17A is closely related to the occurrence and development of atrial fibrillation in the rat model of atrial fibrillation. IL-17A may induce atrial remodeling by affecting the balance of MMPs/TIMPs, leading to the occurrence and development of atrial fibrillation.
【學(xué)位授予單位】：第三軍醫(yī)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R541.75;R-332
本文編號(hào)：2246731
[Abstract]:Background Atrial fibrillation (AF) is one of the most common arrhythmias in clinical practice. In recent years, a new helper T cell subset-Th17 (Th17) and its specific effector interleukin-17 (IL-17) have attracted much attention. IL-17 has been proved to be an important inflammatory mediator in many cardiovascular diseases. Interleukin-17 (IL-17) plays an important role in the development of atrial fibrillation, including atherosclerosis, chronic heart failure, acute coronary syndrome and viral myocarditis. Phase I matched case-control study showed that IL-17A in peripheral plasma was associated with AF, and with the increase of factor levels, the stronger the association was, and it may affect AF by affecting cardiac structural remodeling. However, the specific role and mechanism of IL-17A in the occurrence and maintenance of AF, and the role of IL-17A in peripheral blood and atrial tissue were also discussed. Objective To explore the relationship between IL-17 and atrial fibrillation in SD rats by rapid esophageal atrial pacing, and to analyze the consistency of IL-17A level in peripheral blood with atrial tissue and the relationship between them and atrial fibrosis. The correlation between IL-17A and matrix metalloproteinase (MMP) and tissue inhibitor metalloproteinase (TIMP) was analyzed to further validate the mechanism of IL-17A inducing atrial fibrosis by inducing imbalance of MMPs/TIMPs. Methods 1. A rat model of atrial fibrillation was established by transesophageal rapid atrial pacing, and the changes of electrocardiogram data, including QRS, were compared and analyzed between atrial fibrillation group and control group. The changes of plasma levels of IL-17A and C-reactive protein (CRP) and plasma levels of MMP2, MMP9 and TIMP 2 in AF group and control group were measured by enzyme-linked immunosorbent assay. 3. The levels of IL-17A, MMP2 and MMP in atrial tissues were determined by immunohistochemistry. Pearson correlation analysis was used to analyze the consistency of IL-17A in plasma and atrial tissues and their correlation with atrial fibrosis. The consistency of MMP2, MMP9, TIMP2 in plasma and atrial tissues and their correlation with atrial fibrosis were also analyzed. Result The first chapter was the establishment of rat atrial fibrillation model. 1. The heart rate of rats in AF group increased significantly from (159.63 (+ 18.25) beats per minute in normal time to (203.24 (+ 33.56) beats per minute in AF attack. Meanwhile, the QRS interval and QT interval prolonged significantly from 50.00 (+ 4.28 ms), 103.00 (+ 1.85 ms) to 68.85 (+ 14.73 ms) and 134.80 (+ 22.05) beats in normal time, respectively. The degree of atrial fibrosis in AF group was more serious than that in control group. The volume fraction of collagen in AF group was significantly higher than that in control group [(18.15+9.45)% vs (6.51+4.49)%, P 0.01]. The level of IL-17A in atrial tissue of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). 3. The level of IL-17A in plasma of AF group was significantly higher than that of control group (0.17.05 vs 0.04.01, P = 0.003). The level of IL-17A in plasma was positively correlated with atrial fibrosis (r = 0.830, P = 0.003), and the level of IL-17A in atrial tissue was positively correlated with atrial fibrosis (r = 0.685, P = 0.029). Compared with the control group, the levels of MMP 2 and MMP 9 in atrial tissue of AF group were significantly higher (0.12.05 vs 0.04.02, P = 0.021; 0.08.01 vs 0.03.01, P 0.001), while the levels of TIMP 2 were significantly lower in AF group (0.02.00 vs 0.06.02, P = 0.004). The levels of MMP 2, MMP 9 and TIMP 2 in atrial tissues were positively correlated with atrial fibrosis (r = 0.809, P = 0.005). The levels of TIMP 2 were negatively correlated with atrial fibrosis (r = - 0.884, P = 0.001). No correlation was found between the levels of MMP 2 in atrial tissues and atrial fibrosis (r = 0.599, P = 0.067). 4. The levels of MMP-9 in plasma were positively correlated with IL-17A (r = 0.648, P = 0.043), and TIMP-2 was negatively correlated with IL-17A (r =-0.695, P = 0.037). No correlation was found between the levels of MMP-2 and IL-17A (r = 0.576, P = 0.082). MMP-2, MMP-9 and IL-17A were positively correlated in atrial tissues of AF rats (r = 0.801, P = 0.005; r = 0.778, P = 0.008). Conclusion IL-17A is closely related to the occurrence and development of atrial fibrillation in the rat model of atrial fibrillation. IL-17A may induce atrial remodeling by affecting the balance of MMPs/TIMPs, leading to the occurrence and development of atrial fibrillation.
【學(xué)位授予單位】：第三軍醫(yī)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R541.75;R-332
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 何金輝;;孤立性心房顫動(dòng)患者血清CRP、IL8和IL10水平的變化[J];中西醫(yī)結(jié)合心腦血管病雜志;2014年10期
2 朱寶龍;徐方芳;;肌鈣蛋白T、中介素等因子在大鼠房顫模型中的變化及意義[J];寧夏醫(yī)科大學(xué)學(xué)報(bào);2014年06期
3 官莉;宮原;陳世雄;;IL-17生物學(xué)效應(yīng)與臨床研究進(jìn)展[J];現(xiàn)代免疫學(xué);2014年02期
4 戴天醫(yī);羅太陽;何怡華;谷孝艷;湯日波;董建增;劉小慧;;犬房顫模型心房纖維化對(duì)心房重塑和炎癥水平的影響[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2013年22期
5 陳唐葶;李濤;李妙齡;劉智飛;楊艷;曾曉榮;;心房快速起搏致豚鼠房顫模型建立及心房肌動(dòng)作電位的改變[J];瀘州醫(yī)學(xué)院學(xué)報(bào);2012年06期
6 蘭法定;;心房顫動(dòng)患者血清C反應(yīng)蛋白的變化及意義[J];中國(guó)實(shí)用醫(yī)藥;2011年35期
7 孫冰;劉和平;安佰富;張廣成;;心房顫動(dòng)患者高敏C反應(yīng)蛋白水平的變化及臨床意義[J];中國(guó)老年學(xué)雜志;2011年23期
8 羅助榮;張克己;林毅;鄭磊磊;徐高陽;蓋曉波;;ACS血清OPG、sRANKL與hs-CRP及冠狀動(dòng)脈病變程度的相關(guān)性研究[J];臨床心血管病雜志;2011年07期
9 戴小波;孫萬邦;;IL-17免疫調(diào)節(jié)作用的研究進(jìn)展[J];檢驗(yàn)醫(yī)學(xué)與臨床;2011年06期
10 張榮君;李源;黃衛(wèi)斌;;心房纖顫動(dòng)物模型制作方法現(xiàn)狀及展望[J];實(shí)用心腦肺血管病雜志;2010年11期
相關(guān)碩士學(xué)位論文 前1條
1 劉媛;炎癥因子與房顫的相關(guān)性研究[D];第三軍醫(yī)大學(xué);2016年
，本文編號(hào)：2246731
本文鏈接：http://sikaile.net/yixuelunwen/xxg/2246731.html
最近更新
教材專著
